RxDoctor Payments Data

Kara Menning

Family · Salt Lake City, UTNPI 1396851705

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (45.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Novartis accounts for 63.8% of it on its own, with 22 other manufacturers making up the rest. Among family clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,306in general payments, 2019–2025

Across 80 payments — averaging $66.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$3K
  • Biogen$394
  • TG Therapeutics, Inc.$360
  • AbbVie$181
  • Sanofi Pasteur Inc.$95
  • Genentech, Inc.$89
  • plus $798 from 17 others

What the payments were for

  • Consulting fees$2,40545%
  • Travel & lodging$89917%
  • Food & beverage$2,00238%

General payments by program year

22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,306 in reported general payments places this provider in the 90th percentile of 1,460 family providers in Utah.

See all family providers in Utah →

Other family in Salt Lake City

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →